Stock 4527 ROHTO PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Rohto Pharmaceutical Co.,Ltd.

Equities

4527

JP3982400008

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:34:42 2024-04-19 am EDT 		5-day change 1st Jan Change
2,918 JPY +1.13% Intraday chart for Rohto Pharmaceutical Co.,Ltd. -0.49% +2.66%
Apr. 04 Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen MT
Apr. 04 Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update DJ

Business Summary

ROHTO PHARMACEUTICAL CO., LTD. is a Japan-based company principally engaged in the health and beauty care area. The Company primarily provides eye care-related products, including eye drops and eye lotions; skin care-related products, including dermatological preparations, lip balms, sunscreens and functional cosmetics; oral medication and food-related products, including digestive medicines, Chinese herbal medicines and supplements, as well as extracorporeal test drugs and other products. The Company operates its business in domestic market and overseas markets, including Europe, Asia and America.

Number of employees: 7,176

Sales per Business

JPY in Million2022Weight2023Weight Delta
Skin Care
65.6 %
124,055 62.1 % 156,657 65.6 % +26.28%
Eye Care
20.2 %
43,102 21.6 % 48,180 20.2 % +11.78%
Internal Medicine
11.1 %
25,604 12.8 % 26,588 11.1 % +3.84%
Other
3.0 %
6,884 3.4 % 7,237 3.0 % +5.13%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
57.3 %
121,417 60.8 % 136,668 57.3 % +12.56%
Asia
29.7 %
55,988 28.0 % 70,773 29.7 % +26.41%
America
7.0 %
10,037 5.0 % 16,655 7.0 % +65.94%
Europe
5.1 %
10,297 5.2 % 12,231 5.1 % +18.78%
Others
1.0 %
1,906 1.0 % 2,337 1.0 % +22.61%

Managers

Managers TitleAgeSince
Masashi Sugimoto PSD
 President 62 18-12-31
Kunio Yamada CHM
 Chairman 68 80-03-31
Masamitsu Inoue DFI
 Director of Finance/CFO - -
Atsushi Hiyama BRD
 Director/Board Member 58 20-03-31
Chiharu Takakura BRD
 Director/Board Member 64 20-03-31
Masaya Saito BRD
 Director/Board Member 60 86-03-31
Shinichi Kunisaki BRD
 Director/Board Member 68 06-12-31
Masako Chikaraishi PRN
 Corporate Officer/Principal 65 82-03-31
Hidetoshi Segi PRN
 Corporate Officer/Principal 61 97-05-31
Hideto Kamimura AUD
 Comptroller/Controller/Auditor 65 82-03-31

Members of the board

Members of the board TitleAgeSince
Kunio Yamada CHM
 Chairman 68 80-03-31
Masanori Kimura AUD
 Comptroller/Controller/Auditor 66 82-03-31
Masaya Saito BRD
 Director/Board Member 60 86-03-31
Hideto Kamimura AUD
 Comptroller/Controller/Auditor 65 82-03-31
Hidetoshi Segi PRN
 Corporate Officer/Principal 61 97-05-31
Akie Iriyama BRD
 Director/Board Member 51 19-05-31
Masako Chikaraishi PRN
 Corporate Officer/Principal 65 82-03-31
Haruka Mera BRD
 Director/Board Member 36 20-06-25
Chiharu Takakura BRD
 Director/Board Member 64 20-03-31
Masashi Sugimoto PSD
 President 62 18-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 236,178,310 199,736,821 ( 84.57 %) 8,039,461 ( 3.404 %) 84.57 %

Shareholders

NameEquities%Valuation
MFS International (UK) Ltd.
5.198 %
12,277,300 5.198 % 241 M ¥
MITSUBISHI UFJ FINANCIAL GROUP, INC
4.263 %
10,069,000 4.263 % 197 M ¥
SPARX Asset Management Co., Ltd.
3.471 %
8,198,198 3.471 % 161 M ¥
ROHTO PHARMACEUTICAL CO.,LTD.
3.404 %
8,039,400 3.404 % 158 M ¥
Kiyoko Yamada
2.514 %
5,938,000 2.514 % 116 M ¥
Yamada Family
2.378 %
5,616,000 2.378 % 110 M ¥
Sansho Kosan KK
2.158 %
5,096,000 2.158 % 100 M ¥
Nippon Life Insurance Co.
1.794 %
4,238,000 1.794 % 83 M ¥
Kunio Yamada
1.655 %
3,908,000 1.655 % 77 M ¥
THE HYAKUGO BANK, LTD.
0.8468 %
2,000,000 0.8468 % 39 M ¥

Holdings

NameEquities%Valuation
ROHTO PHARMACEUTICAL CO.,LTD.
3.40%
 8,039,400 3.40% 157,606,166 $
ASICS CORPORATION
0.21%
 408,000 0.21% 19,682,234 $
MITSUBISHI UFJ FINANCIAL GROUP, INC
0.01%
 1,380,000 0.01% 14,197,095 $
OHKI HEALTHCARE HOLDINGS CO.,LTD.
12.50%
 1,759,523 12.50% 11,509,656 $
MATSUKIYOCOCOKARA & CO.
0.16%
 665,700 0.16% 10,730,285 $
YAKULT HONSHA CO.,LTD.
0.10%
 346,600 0.10% 7,142,920 $
MORISHITA JINTAN CO., LTD.
8.55%
 355,000 8.55% 5,791,371 $
EUGLENA CO., LTD.
0.79%
 1,069,500 0.79% 4,282,385 $
SUMITOMO MITSUI FINANCIAL GROUP, INC.
0.01%
 71,100 0.01% 4,185,338 $
MEIJI HOLDINGS CO LTD
0.06%
 180,400 0.06% 4,036,039 $

Company contact information

Rohto Pharmaceutical Co., Ltd.

1-8-1 Tatsumi-nishi Ikuno-Ku

544-8666, Osaka

+

http://www.rohto.co.jp
address Rohto Pharmaceutical Co.,Ltd.(4527)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Rohto Pharmaceutical Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2,886 JPY
Average target price
3,892 JPY
Spread / Average Target
+34.88%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ROHTO PHARMACEUTICAL CO.,LTD. Stock Rohto Pharmaceutical Co.,Ltd.
+2.66% 4.26B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+27.97% 672B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+23.76% 550B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.02% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+14.85% 317B
ABBVIE INC. Stock AbbVie Inc.
+6.25% 292B
ASTRAZENECA PLC Stock AstraZeneca PLC
+2.28% 211B
NOVARTIS AG Stock Novartis AG
-0.42% 203B
ROCHE HOLDING AG Stock Roche Holding AG
-9.94% 194B
PFIZER, INC. Stock Pfizer, Inc.
-11.81% 144B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4527 Stock
  4. Company Rohto Pharmaceutical Co.,Ltd.